Breast Cancer CDK 4/6 Inhibition

Home > Breast Cancer CDK 4/6 Inhibition
Breast Cancer CDK 4/6 Inhibition Breast Cancer CDK 4/6 Inhibition
Breast Cancer CDK 4/6 Inhibition Breast Cancer CDK 4/6 Inhibition
  • Skill Levelintermediate
  • Enrolled 1,207 students enrolled
Enquire now

Key concepts covered include:

By the end of this module, you should be able to:

  • Focus on CDK4 and 6 as key regulators of the G1- S transition of the cell cycle.
  • Acknowledge that an array of substrates for CDK4 and 6 have been identified, including the retinoblastoma protein, RB1, which can potentially lead to drug target discovery.
  • Describe the mechanisms and clinical implications of endocrine resistance.
  • Define an evidence-based algorithm for the management of hormone-positive breast cancer progressing on endocrine therapy.
  • Define a differential algorithm for primary and secondary endocrine-resistant breast carcinoma.
  • Establish a paradigmatic sequential path of clinical utility to drive therapeutic decision-making of your working group.
  • Illustrate the hypothetical role of CDK4/6 inhibitors in the neoadjuvant and adjuvant settings of care.
  • Assess adequately and treat early the preventable adverse events of CDK4/6 inhibitors with a special focus on neutropenia.
  • Explain the clinical benefit of CDK 4/6 inhibitors.
  • Learn how to manage the side effects of CDK4/6 inhibitors.
  • Be aware of adverse events and challenges.
  • Share your knowledge with your oncology team and your patients.

What you'll learn

This course is a collection of modules on breast cancer CDK 4/6 inhibition, developed to support the professional development of three distinct healthcare professions.

Instructor

ecancer

ecancer – Oncology
4/5

ecancer’s mission is to raise the standards of care for cancer patients across the world through education.

Home > Breast Cancer CDK 4/6 Inhibition
Course Preview
Breast Cancer CDK 4/6 Inhibition Breast Cancer CDK 4/6 Inhibition

Instructor

ecancer

ecancer – Oncology
4/5

ecancer’s mission is to raise the standards of care for cancer patients across the world through education.

For: intermediates
Last Updated 07/2021

Other Top Rated Courses by ecancer

Related Courses

read more

82 Users Enrolled
1 Video

https://storage.googleapis.com/master-transformer-9446/DOSILY/Kite%20to%20Dosily%203/Quality%20Improvement%20Activity%20for%20the%20Early%20Diagnosis%20of%20Cancer%20(QOF%2020-21)/Quality%20Improvement%20activity%20for%20the%20early%20diagnosis%20of%20cancer(QOF%2020-21)_Explainer.mp4

Quality Improvement Activity for the Early Diagnosis of Cancer (QOF 20/21)

NB Medical Education
5.5K
4/5
O— Oncology

free

Enquire here!

×

Our alumni and partners

Copyright 2021 Dosily.com

Terms of use | Privacy Policy

Dismiss ad

This will close in 0 seconds

X
or
or

Have an account?